Hostname: page-component-cb9f654ff-65tv2 Total loading time: 0 Render date: 2025-08-01T14:44:18.025Z Has data issue: false hasContentIssue false
  • English
  • Français

Chromosome Aberrations and LSD

A Controlled Study in 50 Psychiatric Patients

Published online by Cambridge University Press:  29 January 2018

J. T. Robinson ,
R. G. Chitham ,
R. M. Greenwood  and
J. W. Taylor
J. T. Robinson
Affiliation:
Roffey Park Hospital, Horsham, Sussex
R. G. Chitham
Affiliation:
Area Cytogenetic Unit, St. Ebba's Hospital, Epsom, Surrey
R. M. Greenwood
Affiliation:
M.R.C. Computer Unit, 242 Pentonville Road, London, N.1
J. W. Taylor
Affiliation:
Area Cytogenetic Unit, St. Ebba's Hospital, Epsom, Surrey
Get access Rights & Permissions [Opens in a new window]

Extract

While the beneficial effect of lysergic acid diethylamide (LSD) in the treatment of carefully selected patients as an adjunct to psychotherapy has been amply reported (Robinson et al., 1963), concern has been expressed regarding the damage to chromosomes in those taking the drug.

Information

Type
Research Article
Information
The British Journal of Psychiatry , Volume 125 , Issue 586 , September 1974 , pp. 238 - 244
Copyright
Copyright © Royal College of Psychiatrists, 1974 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Alexander, G. J., Miles, B. E., Gold, G. M. & Alexander, R. B. (1967) LSD injected early in pregnancy produces abnormalities in offspring of rats. Science, 157, 459—60.CrossRefGoogle ScholarPubMed
Armitage, P. (1971) Statistical Methods in Medical Research, pp. 324–30. Oxford and Edinburgh: Blackwell Scientific Publications.Google Scholar
Auerbach, E. R. & Rugowski, J. A. (1967) Lysergic acid diethylamide effect on embryos. Science, 157, 1325—6.CrossRefGoogle ScholarPubMed
Bender, I. & Sankar, D. V. S. (1968) Chromosomal damage not found in leucocytes of children treated with LSD. Science, 159, 749.CrossRefGoogle Scholar
Buckton, K. E. & Pike, M. C. (1964) Int. J. Rad. Biol, 8, 439—52.Google Scholar
Cohen, M. M., Hirschhorn, K. & Frosch, W. A. (1967a) In vivo and in vitro chromosomal damaged induced by LSD25. New Eng. J. Med., 277, 1043—9.CrossRefGoogle ScholarPubMed
Cohen, M. M., Marinello, M. J. & Buck, N. (1967b) Chromosomal damage in human leucocytes induced by lysergic acid diethylamide. Science, 155, 1417—9.CrossRefGoogle ScholarPubMed
Birth Defects. Original Article Series. Chicago Conference on Standardization in Human Cytogenetics. December 1966. Vol. 2. No. 2. Published by National Foundation March of Dimes.Google Scholar
Egozcue, J., Irwin, S. & Maruffo, C. A. (1968) Chromosome damage in LSD users. J. Amer. med. Assoc., 204, 214—18.CrossRefGoogle Scholar
Geber, W. F. (1967) Congenital malformations induced by mescaline, lysergic acid diethylamide and bromlysergic acid in the hamster. Science, 158, 256—6.CrossRefGoogle Scholar
Hsu, L. Y., Strauss, L. & Hirschhorn, K. (1970) Chromosome abnormality in offspring of LSD user. J. Amer. med. Assoc., 211, no. 6, 987–90.CrossRefGoogle ScholarPubMed
Irwin, S. & Egozcue, J. (1967) Chromosomal abnormalities in leucocytes from LSD25 users. Science, 157, 313—14.CrossRefGoogle ScholarPubMed
Lloyd, D. C., Purrott, R. J. & Dolphin, G. W. (1973) Chromosome aberration dosimetry used in studying a case of over-exposure to radiation. Nature, 241, 69—70.CrossRefGoogle Scholar
Long, Sally Y. (1972) Does LSD induce chromosomal damage and malformations? A review of the literature. Teratology, 6, 75—90.CrossRefGoogle ScholarPubMed
Lugas, G. T. & Wolfgang, L. (1970) Chromosomal effects of LSD25 a controversy. J. Arkansas med. Soc., 6, no. 10, 348–9.Google Scholar
Moorhead, P. S., Nowell, P. C., Mellman, W. J., Battips, D. M. & Hungerford, D. A. (1960) Exp. Cell Res., 20, 613—16.CrossRefGoogle Scholar
Nielsen, J., Frederich, U., Jacobsen, E. & Tsuboi, T. (1968) Lysergide and chromosome abnormalities. Brit. med. J., 2, 801—803.CrossRefGoogle ScholarPubMed
Nielsen, J., Frederich, U., & Tsuboi, T. (1969) Chromosome abnormalities in patients treated with chlorpromazine, perphenazine and lysergide. Brit. med. J., 3, 634—6.CrossRefGoogle ScholarPubMed
Robinson, J. T., Davies, L. S., Sack, E. L. & Morrisey, J. D. (1963) A controlled trial of abreaction with lysergic acid diethylamine (LSD25). Brit. J. Psychiat., 109, 45—68.CrossRefGoogle Scholar
Rumke, Chr. L. (1964) Some limitation of animal tests. In Evaluation of Drug Activities: Pharmacometrics (by Laurence, D. R. & Bacharach, A. L.). Vol. 1, chapter 5, pp. 125–35. Academic Press.Google Scholar
Stenchever, M. A. & Jarvis, J. A. (1970) Lysergic acid diethylamide (LSD) effect on human chromosomes in vivo. Amer. J. Obs. & Gynaec., 106, no. 4, 485–6.Google ScholarPubMed
Tjio, Joe Hin, Pahnke, W. N. & Kurland, A. A. (1969) LSD and chromosomes. A controlled experiment. J. Amer. med. Assoc., 210, no. 5, 849–56.CrossRefGoogle ScholarPubMed
Zellweger, H., McDonald, J. S. & Abbo, G. (1967) Is lysergide a teratogen? Lancet, ii, 1066—8.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.